Last update 03 Jun 2026

UI-102

Overview

Basic Info

Drug Type
T-lymphocyte cell therapy
Synonyms
UI 102, UI102
Target
TLR
Action
antagonists
Mechanism
TLR antagonists(Toll-like receptor antagonists)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Advanced cancerLocally Advanced Malignant Solid NeoplasmHepatocellular Carcinoma
Inactive Indication-
Originator Organization
United Immunity Co. Ltd.United Immunity Co. Ltd.
Active Organization
United Immunity Co. Ltd.United Immunity Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with UI-102
NCT07605962
/ RecruitingPhase 1/2
A Phase I/II Open-Label, Dose Escalation, Dose Optimization, and Cohort Expansion Trial to Investigate the Safety, Pharmacokinetics and Pharmacodynamics of UI-102, a Novel Cholesteryl Pullulan (CHP) Nanoparticle-formulated TLR7/8 Agonist in Patients With Selected Locally Advanced and/or Metastatic Solid Tumors
100 Clinical Results associated with UI-102
Login to view more data
100 Translational Medicine associated with UI-102
Login to view more data
100 Patents (Medical) associated with UI-102
Login to view more data
100 Deals associated with UI-102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced cancerPhase 2
United States
United Immunity Co. Ltd.United Immunity Co. Ltd.
20 May 2026
Locally Advanced Malignant Solid NeoplasmPhase 2
United States
United Immunity Co. Ltd.United Immunity Co. Ltd.
20 May 2026
Hepatocellular CarcinomaPreclinical
Japan
United Immunity Co. Ltd.United Immunity Co. Ltd.
01 Feb 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free